Abstract
Seventy percent of the mice receiving (S,S)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethandiol (A36683) in their drinking water lived at least four times longer than control mice when infected with 10 or 100 mean lethal doses of lymphocytic choriomeningitis virus strain UBC. In the next 4 months, most of the survivors died with lymphocytic choriomeningitis-like symptoms. Drug treatment during the first 7 days after infection was found to have no significant effect on virus titers in various organs. The sparing effect of the drug is discussed in terms of immunosuppression.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- EGGERS H. J., TAMM I. Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole. J Exp Med. 1961 Apr 1;113:657–682. doi: 10.1084/jem.113.4.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gilden D. H., Cole G. A., Monjan A. A., Nathanson N. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med. 1972 Apr 1;135(4):860–873. doi: 10.1084/jem.135.4.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pulkkinen A. J., Pfau C. J. Plaque size heterogeneity: a genetic trait of lymphocytic choriomeningitis virus. Appl Microbiol. 1970 Jul;20(1):123–128. doi: 10.1128/am.20.1.123-128.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shipkowitz N. L., Bower R. R., Schleicher J. B., Aquino F., Appell R. N., Roderick W. R. Antiviral activity of a bis-benzimidazole against experimental rhinovirus infections in chimpanzees. Appl Microbiol. 1972 Jan;23(1):117–122. doi: 10.1128/am.23.1.117-122.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stella J. P., Yankaskas K. D., Morgan J. H., Fox M. P., Pfau C. J. Characteristics of the in vitro inhibition of arenavirus synthesis by bis-benzimidazoles. Antimicrob Agents Chemother. 1974 Dec;6(6):747–753. doi: 10.1128/aac.6.6.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- VOLKERT M., LARSEN J. H., PFAU C. STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 4. THE QUESTION OF IMMUNITY IN ADOPTIVELY IMMUNIZED VIRUS CARRIERS. Acta Pathol Microbiol Scand. 1964;61:268–282. doi: 10.1111/apm.1964.61.2.268. [DOI] [PubMed] [Google Scholar]